Tozaro
Synthetic Smart Polymer affinity ligands for purifying viral vectors and biologics, for cell and gene therapy manufacturers
Highlights
- New on EvolcAdded 2026-10-30
About Tozaro
Tozaro develops Smart Polymer™ synthetic affinity ligands for downstream bioprocessing. Its platform combines computational modelling, machine learning and chemical synthesis to design ligands tailored to a specific target and chromatography application.
The company's first products focus on viral vector purification, including lentivirus and AAV. It works with biotechs, CDMOs and academia on purification solutions for advanced therapies, and its stated mission is to commercialise Smart Polymer reagents.
Tozaro is registered in the United Kingdom, with its headquarters in Sharnbrook, and was founded in 2015. Its leadership team includes Chief Executive Officer Jason Slingsby and Chief Financial Officer Guy Leaver.
Product: Smart Polymer™ synthetic affinity ligands (bead, membrane and monolith formats) for viral vector and biologics purification.
Jobs at Tozaro
Leadership
- Jason Slingsby · Chief Executive OfficerSource: company website
- Bea Burke · Chief Commercial OfficerSource: company website
- Daniel Smith · Chief Technical OfficerSource: company website
- Guy Leaver · Chief Financial OfficerSource: company website
- Keli Stockbridge · Head of Marketing and Commercial OperationsSource: company website
More biotech & pharma companies
Treos Bio
Develops peptide-based cancer immunotherapies for patients and pharmaceutical development partnersNew on EvolcTrimtech Therapeutics
Develops small-molecule protein degraders for Alzheimer's, Parkinson's and other neurodegenerative and inflammatory diseasesYoung companyNew on EvolcVeramed
Clinical trial biometrics services (data management, biostatistics, programming) for pharma and biotech sponsorsNew on EvolcVerdiva Bio
Develops once-weekly peptide medicines for obesity and cardiometabolic disease, with a lead drug in Phase 2 trialsYoung companyNew on EvolcWaymade PLC
Specialty pharmaceutical company developing, licensing and commercialising generic and niche medicines for patients worldwideNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Tailwind CSS
- WordPress
- jQuery
- nginx